Impact of Critical Illness Polyneuromyopathy in Rehabilitation: A Prospective Observational Study

Background Critical illness polyneuromyopathy (CIPNM) increasingly is recognized as a source of disability in patients requiring intensive care unit (ICU) admission. The prevalence and impact of CIPNM on patients in the rehabilitation setting has not been established. Objectives To determine the proportion of at‐risk rehabilitation inpatients with evidence of CIPNM and the functional sequelae of this disorder. Design Prospective observational study. Setting Tertiary academic rehabilitation hospital. Patients Rehabilitation inpatients with a history of ICU admission for at least 72 hours. Methods Electrodiagnostic studies were performed to evaluate for axonal neuropathy and/or myopathy in at least one upper and one lower limb. Main Outcome Measurements The primary outcome was prevalence of CIPNM. Secondary outcomes included Functional Independence Measure (FIM) scores, rehabilitation length of stay (RLOS), and discharge disposition. Results A total of 33 participants were enrolled; 70% had evidence of CIPNM. Admission FIM score, discharge FIM, FIM gain, and FIM efficiency were 64.1, 89.9, 25.5, and 0.31 in those with CIPNM versus 78.4, 94.6, 16.1, and 0.33 in those without CIPNM, respectively. Average RLOS was 123 days versus 76 days and discharge to home was 57% versus 90% in the CIPNM and non‐CIPNM groups, respectively. Conclusions CIPNM is very common in rehabilitation inpatients with a history of ICU admission. It was associated with a lower functional status at rehabilitation admission, but functional improvement was at a similar rate to those without CIPNM. Longer RLOS stay may be required to achieve the same functional level. Level of Evidence III